Gender as an independent risk factor for herpes zoster: a population-based prospective study.

scientific article published on 3 March 2006

Gender as an independent risk factor for herpes zoster: a population-based prospective study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ANNEPIDEM.2005.12.002
P698PubMed publication ID16516488
P5875ResearchGate publication ID7262497

P50authorFrançois G SchellevisQ86028053
P2093author name stringKarel G M Moons
Theo J M Verheij
Wim Opstelten
Gerrit A Van Essen
P433issue9
P921main subjectherpes zosterQ182155
risk factorQ1475848
P304page(s)692-695
P577publication date2006-03-03
P1433published inAnnals of EpidemiologyQ4767848
P1476titleGender as an independent risk factor for herpes zoster: a population-based prospective study.
P478volume16

Reverse relations

cites work (P2860)
Q33652679A case control study on family history as a risk factor for herpes zoster and associated outcomes, Beijing, China.
Q37903995A refresher on herpes zoster, current status on vaccination, and the role of the dermatologist
Q33657323Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands
Q64236311Association between statin use and herpes zoster: systematic review and meta-analysis
Q36015879Association of Herpes Zoster and Type 1 Diabetes Mellitus
Q38884360Asthma status is an independent risk factor for herpes zoster in children: a population-based cohort study
Q34291150Cost-effectiveness of vaccination against herpes zoster
Q85888006Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands
Q35982768Disease Burden Due to Herpes Zoster among Population Aged ≥50 Years Old in China: A Community Based Retrospective Survey
Q37694187Disseminated herpes zoster ophthalmicus in an immunocompetent 8-year old boy.
Q56768031Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom
Q35607755Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain.
Q34064838Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study
Q33574978Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain).
Q38423324Examination of links between herpes zoster incidence and childhood varicella vaccination
Q37663817Herpes Zoster with Post Herpetic Neuralgia Involving the Right Maxillary Branch of Trigeminal Nerve: A Case Report and Review of Literature
Q37330295Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient
Q38831062Herpes zoster and the search for an effective vaccine
Q34158156Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination
Q58610982Herpes zoster increased risk of neuralgic amyotrophy: a retrospective, population-based matched cohort study
Q38636456Herpes zoster prevention: A difficult problem to solve
Q34875123Herpes zoster vaccine (HZV): utilization and coverage 2009 - 2013, Alberta, Canada
Q51153443Herpes zoster: Burden of disease in France
Q33591264Impact of varicella vaccine on varicella-zoster virus dynamics
Q33637650Incidence and risk factors for herpes zoster following heart transplantation.
Q34801907Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United States
Q37670193Incidence of herpes zoster in patients with altered immune function
Q36169787Increasing incidence associated with herpes zoster infection in British Columbia, Canada
Q47303827Letter to the Editor regarding "The role of age-sex interaction in the development of post-herpetic neuralgia".
Q37383627Mitochondrial Haplogroups as a Risk Factor for Herpes Zoster.
Q36998853Postherpetic neuralgia: epidemiology, pathophysiology and management
Q26852530Predictors of shingles reports at diagnosis of common variable immunodeficiency and selective immunoglobulin G subclass deficiency in 212 Alabama adults
Q34352218Presentation and management of herpes zoster (shingles) in the geriatric population
Q89497860Risk Factors for Herpes Zoster Infection: A Meta-Analysis
Q41577013Risk factors for herpes zoster in a large cohort of unvaccinated older adults: a prospective cohort study.
Q35556161Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study
Q57075974Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study
Q39765566Self-reported herpes zoster, pain, and health care seeking in the Health and Retirement Study: implications for interpretation of health care-based studies
Q30251721Sex differences in the incidence of skin and skin-related diseases in Olmsted County, Minnesota, United States, and a comparison with other rates published worldwide
Q40921109Short-term dipeptidyl peptidase-4 inhibitor use increases the risk of herpes zoster infection in Asian patients with diabetes
Q26824836Similar herpes zoster incidence across Europe: results from a systematic literature review
Q33578057Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain)
Q33795551Systematic review of incidence and complications of herpes zoster: towards a global perspective.
Q37234339The Shozu Herpes Zoster (SHEZ) study: rationale, design, and description of a prospective cohort study
Q35155350The epidemiology of herpes zoster and its complications in Medicare cancer patients.
Q42250014Varicella zoster virus infection occurs at a relatively young age in The Netherlands